back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-23 20:01 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-200,000 vol |
0 | |
| Filed 2022-07-28 15:32 Tx date 2022-07-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$260.00
+2,000 vol $0.13 each |
200,000 | |
| Filed 2022-07-28 15:31 Tx date 2022-07-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,340
+18,000 vol $0.13 each |
198,000 | |
| Filed 2022-07-28 15:31 Tx date 2022-07-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$625.00
+5,000 vol $0.125 each |
180,000 | |
| Filed 2022-07-28 15:27 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,175
+10,000 vol $0.1175 each |
175,000 | |
| Filed 2022-07-28 15:25 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,116
+9,500 vol $0.1175 each |
165,000 | |
| Filed 2022-07-28 15:24 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,116
+9,500 vol $0.1175 each |
155,500 | |
| Filed 2022-07-28 15:19 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+20,000 vol $0.1175 each |
146,000 | |
| Filed 2022-07-28 15:19 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,788
+24,000 vol $0.1162 each |
126,000 | |
| Filed 2022-07-28 15:18 Tx date 2022-07-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238.60
+2,000 vol $0.1193 each |
102,000 | |
| Filed 2022-06-13 11:33 Tx date 2022-06-08 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+300,000 vol $0.175 each |
570,000 | |
| Filed 2022-02-07 12:30 Tx date 2022-02-03 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,080
+25,000 vol $0.2432 each |
100,000 | |
| Filed 2022-02-07 12:30 Tx date 2022-02-03 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,250
+25,000 vol $0.25 each |
75,000 | |
| Filed 2021-08-27 12:13 Tx date 2021-08-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,845
+4,500 vol $0.41 each |
50,000 | |
| Filed 2021-08-27 12:10 Tx date 2021-08-27 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,290
+24,500 vol $0.42 each |
45,500 | |
| Filed 2021-08-27 11:11 Tx date 2021-08-26 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
270,000 | |
| Filed 2021-08-04 20:11 Tx date 2021-07-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
120,000 | |
| Filed 2021-05-06 11:34 Tx date 2021-05-06 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,675
+5,500 vol $0.85 each |
21,000 | |
| Filed 2021-05-06 11:28 Tx date 2021-05-06 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,750
+5,000 vol $0.95 each |
15,500 | |
| Filed 2021-05-06 11:27 Tx date 2021-05-06 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,775
+5,000 vol $0.95 each |
10,500 | |
| Filed 2021-05-06 11:25 Tx date 2021-05-06 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,950
+5,000 vol $0.99 each |
5,500 | |
| Filed 2021-05-06 11:23 Tx date 2021-05-06 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+500 vol $1.00 each |
500 | |
| Filed 2021-05-04 09:52 Tx date 2021-04-29 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-04 09:52 Tx date 2021-04-29 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,520
-1,000 vol $9.52 each |
22,310 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,100
-2,000 vol $9.55 each |
20,310 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,160
-2,000 vol $9.58 each |
18,310 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,475
-1,500 vol $9.65 each |
14,810 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,810
-500 vol $9.62 each |
14,310 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,800
-3,000 vol $9.60 each |
11,310 | |
| Filed 2018-10-09 Tx date 2018-10-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,260
-2,000 vol $9.63 each |
16,310 | |
| Filed 2018-04-12 Tx date 2018-04-10 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,320
-1,000 vol $9.32 each |
25,810 | |
| Filed 2018-04-12 Tx date 2018-04-10 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,665
-500 vol $9.33 each |
25,310 | |
| Filed 2018-04-12 Tx date 2018-04-10 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,340
-1,000 vol $9.34 each |
24,310 | |
| Filed 2018-04-12 Tx date 2018-04-10 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,370
-1,000 vol $9.37 each |
23,310 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,200
-14,400 vol $0.50 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-155,100
-16,500 vol $9.40 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-155,100
-16,500 vol $9.40 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,601
-700 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,130
-1,500 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,130
-1,500 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,450
-1,000 vol $9.45 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,450
-1,000 vol $9.45 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,860
-2,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,860
-2,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-108,215
-11,500 vol $9.41 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-108,215
-11,500 vol $9.41 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,181
-1,300 vol $9.37 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,181
-1,300 vol $9.37 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,574
-2,300 vol $9.38 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-34,854
-3,700 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-34,854
-3,700 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-122,590
-13,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-122,590
-13,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-56,640
-6,000 vol $9.44 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-56,640
-6,000 vol $9.44 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-28,260
-3,000 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,250
-62,500 vol $0.50 each |
181,486 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,574
-2,300 vol $9.38 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$155,100
+16,500 vol $9.40 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$155,100
+16,500 vol $9.40 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,601
-700 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,601
+700 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,601
+700 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,130
+1,500 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,130
+1,500 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,450
+1,000 vol $9.45 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,450
+1,000 vol $9.45 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,860
+2,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,860
+2,000 vol $9.43 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$108,215
+11,500 vol $9.41 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$108,215
+11,500 vol $9.41 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,180
+1,300 vol $9.37 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,180
+1,300 vol $9.37 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,574
+2,300 vol $9.38 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,574
+2,300 vol $9.38 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$34,854
+3,700 vol $9.42 each |
||
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,250
+62,500 vol $0.50 each |
90,090 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-155,100
-16,500 vol $9.40 each |
73,590 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,461
-2,700 vol $9.43 each |
70,890 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,984
-5,200 vol $9.42 each |
65,690 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,450
-1,000 vol $9.45 each |
64,690 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-108,215
-11,500 vol $9.41 each |
53,190 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,181
-1,300 vol $9.37 each |
51,890 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-122,590
-13,000 vol $9.43 each |
38,890 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,574
-2,300 vol $9.38 each |
36,590 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-56,640
-6,000 vol $9.44 each |
30,590 | |
| Filed 2018-04-12 Tx date 2018-04-09 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,260
-3,000 vol $9.42 each |
27,590 | |
| Filed 2018-04-12 Tx date 2018-04-10 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,410
-780 vol $9.50 each |
26,810 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,106
+28,986 vol $9.56 each |
243,986 | |
| Filed 2017-11-17 Tx date 2017-11-16 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,272
+940 vol $6.67 each |
27,590 | |
| Filed 2017-11-17 Tx date 2017-11-16 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,345
+500 vol $6.69 each |
26,650 | |
| Filed 2017-04-07 Tx date 2017-04-07 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$238,400
+40,000 vol $5.96 each |
215,000 | |
| Filed 2016-12-07 Tx date 2016-12-05 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$31,000
+10,000 vol $3.10 each |
26,150 | |
| Filed 2016-04-04 Tx date 2016-04-04 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
175,000 | |
| Filed 2016-02-26 Tx date 2016-02-26 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
200,290 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
225,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,125
+75,000 vol $0.415 each |
125,000 | |
| Filed 2015-08-20 Tx date 2013-11-05 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Holder: Claude Perrotte (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Holder: Claude Perrotte (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$45,000
+132,159 vol $0.3405 each |
132,159 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$34,999
+102,790 vol $0.3405 each |
150,290 | |
| Filed 2015-05-04 Tx date 2013-12-13 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-04 Tx date 2015-05-01 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,177
+9,900 vol $1.23 each |
16,150 | |
| Filed 2015-05-04 Tx date 2015-05-01 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62.00
+50 vol $1.24 each |
50 | |
| Filed 2015-05-04 Tx date 2015-05-01 |
$TH
Theratechnologies Inc. |
Fortin, Lyne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,564
+6,200 vol $1.22 each |
6,250 |